Matthews, M., Aschner, J., Stark, A., Moore, P., Slaughter, J., Steele, S., . . . Maitre, N. (2016). Increasing F2-isoprostanes in the first month after birth predicts poor respiratory and neurodevelopmental outcomes in very preterm infants. J Perinatol.
Citación estilo ChicagoMatthews, MA, et al. "Increasing F2-isoprostanes in the First Month After Birth Predicts Poor Respiratory and Neurodevelopmental Outcomes in Very Preterm Infants." J Perinatol 2016.
Cita MLAMatthews, MA, et al. "Increasing F2-isoprostanes in the First Month After Birth Predicts Poor Respiratory and Neurodevelopmental Outcomes in Very Preterm Infants." J Perinatol 2016.
Precaución: Estas citas no son 100% exactas.